EFL 200
Alternative Names: EFL-200Latest Information Update: 23 Nov 2018
At a glance
- Originator iNtRON Biotechnology
- Class Antibacterials; Endolysins; Proteins
- Mechanism of Action Cell wall inhibitors; Peptidoglycan modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase Unknown Vancomycin-resistant enterococcal infections